James J. Bass
University of Auckland
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James J. Bass.
The Journal of Physiology | 2009
Jenny M. Oldham; Claire C. Osepchook; Ferenc Jeanplong; Shelley J. Falconer; Kenneth G. Matthews; John V. Conaglen; David F. Gerrard; Heather K. Smith; Richard J. Wilkins; James J. Bass; Christopher D. McMahon
Myostatin inhibits myogenesis and there is reduced abundance of the mature protein in skeletal muscles of adult male compared with female mice. This reduction probably occurs after translation, which suggests that it is a regulated mechanism to reduce the availability of myostatin in males. Reduced myostatin may, thereby, contribute to the development of sexually dimorphic growth of skeletal muscle. Our first objective was to determine if the decrease in mature myostatin protein occurs before the linear growth phase to aid growth, or afterwards to maintain the mass of adult muscle. Mice were killed from 2 to 32 weeks and the gastrocnemius muscle was excised. Myostatin mRNA increased from 2 to 32 weeks and was higher in males than females (P < 0.001). In contrast, mature protein decreased in males after 6 weeks (P < 0.001). Our second objective was to determine if growth hormone (GH) induces the decrease in mature myostatin protein. GH increased myostatin mRNA and decreased the abundance of mature protein in hypophysectomised mice (P < 0.05). Our final objective was to determine if the decrease in mature protein occurs in skeletal muscles of male Stat5b−/− mice (Stat5b mediates the actions of GH). As expected, mature myostatin protein was not reduced in Stat5b−/− males compared with females. However, myostatin mRNA remained higher in males than females irrespective of genotype. These data suggest that: (1) the decrease in mature myostatin protein is developmentally regulated, (2) GH acting via Stat5b regulates the abundance of mature myostatin and (3) GH acts via a non‐Stat5b pathway to regulate myostatin mRNA.
PLOS ONE | 2014
Heather K. Smith; Kenneth G. Matthews; Jenny M. Oldham; Ferenc Jeanplong; Shelley J. Falconer; James J. Bass; Mônica Senna-Salerno; Jeremy Bracegirdle; Christopher D. McMahon
Skeletal muscles of myostatin null (Mstn(−/−)) mice are more susceptible to atrophy during hind limb suspension (HS) than are muscles of wild-type mice. Here we sought to elucidate the mechanism for this susceptibility and to determine if Mstn(−/−) mice can regain muscle mass after HS. Male Mstn(−/−) and wild-type mice were subjected to 0, 2 or 7 days of HS or 7 days of HS followed by 1, 3 or 7 days of reloading (n = 6 per group). Mstn(−/−) mice lost more mass from muscles expressing the fast type IIb myofibres during HS and muscle mass was recovered in both genotypes after reloading for 7 days. Concentrations of MAFbx and MuRF1 mRNA, crucial ligases regulating the ubiquitin-proteasome system, but not MUSA1, a BMP-regulated ubiquitin ligase, were increased more in muscles of Mstn(−/−) mice, compared with wild-type mice, during HS and concentrations decreased in both genotypes during reloading. Similarly, concentrations of LC3b, Gabarapl1 and Atg4b, key effectors of the autophagy-lysosomal system, were increased further in muscles of Mstn(−/−) mice, compared with wild-type mice, during HS and decreased in both genotypes during reloading. There was a greater abundance of 4E-BP1 and more bound to eIF4E in muscles of Mstn(−/−) compared with wild-type mice (P<0.001). The ratio of phosphorylated to total eIF2α increased during HS and decreased during reloading, while the opposite pattern was observed for rpS6. Concentrations of myogenic regulatory factors (MyoD, Myf5 and myogenin) mRNA were increased during HS in muscles of Mstn(−/−) mice compared with controls (P<0.001). We attribute the susceptibility of skeletal muscles of Mstn(−/−) mice to atrophy during HS to an up- and downregulation, respectively, of the mechanisms regulating atrophy of myofibres and translation of mRNA. These processes are reversed during reloading to aid a faster rate of recovery of muscle mass in Mstn(−/−) mice.
Domestic Animal Endocrinology | 2015
Ferenc Jeanplong; Claire C. Osepchook; Shelley J. Falconer; Heather K. Smith; James J. Bass; Christopher D. McMahon; Jenny M. Oldham
Undernutrition suppresses the growth of skeletal muscles and alters the expression of insulin-like growth factor 1 (IGF1), a key mitogen, and myostatin, a potent inhibitor of myogenesis. These changes can explain, at least in part, the reduced growth of skeletal muscles in underfed lambs. We have recently identified a myostatin splice variant (MSV) that binds to and antagonizes the canonical signaling of myostatin. In the present study, we hypothesized that the expression of MSV would be reduced in conjunction with myostatin and IGF1 in response to underfeeding in skeletal muscles of sheep. Young growing ewes were fed either ad libitum or an energy-restricted diet (30% of maintenance requirements) for 28 d. This regime of underfeeding resulted in a 24% reduction in body mass (P < 0.001) and a 36% reduction in the mass of the semitendinosus muscles relative to controls (P < 0.001) by day 28. The concentrations of MSV and IGF1 messenger RNA (mRNA) were reduced (both P < 0.001), but myostatin mRNA was not altered in semitendinosus muscles. Unlike the reduced expression of mRNA, the abundance of MSV protein was increased (P < 0.05) and there was no change in the abundance of myostatin protein. Our results suggest that undernutrition for 28 d decreases the signaling of myostatin by increasing the abundance of MSV protein. Although this action may reduce the growth inhibitory activity of myostatin, it cannot prevent the loss of growth of skeletal muscles during undernutrition.
American Journal of Physiology-endocrinology and Metabolism | 2003
Christopher D. McMahon; Ljiljana Popovic; Jenny M. Oldham; Ferenc Jeanplong; Heather K. Smith; Ravi Kambadur; Mridula Sharma; Linda Maxwell; James J. Bass
Heart Lung and Circulation | 2008
Violaine Carpenter; Kenneth G. Matthews; Gerard Devlin; Selwyn Stuart; Juliet Jensen; John V. Conaglen; Ferenc Jeanplong; Paul H. Goldspink; Shi Yu Yang; Geoffrey Goldspink; James J. Bass; Christopher D. McMahon
Archive | 2001
James J. Bass; Carole Berry; Ravi Kambadur; Mridula Sharma; Mark Thomas
Heart Lung and Circulation | 2005
Kenneth G. Matthews; G. Devlin; Selwyn Stuart; Juliet Jensen; Robert N. Doughty; John V. Conaglen; James J. Bass
Archive | 1999
James J. Bass; Ferenc Jeanplong; Ravi Kambadur; Mridula Sharma
/data/revues/14439506/v12i2/S1443950603902435/ | 2011
Kenneth G. Matthews; Gerard Devlin; Selwyn Stuart; Juliet Jensen; Robert N. Doughty; John V. Conaglen; James J. Bass
Archive | 1999
James J. Bass; Ferenc Jeanplong; Ravi Kambadur; Mridula Sharma